The MPhil in Bioscience Enterprise (MBE) at the University of Cambridge is a multidisciplinary program combining biotechnology, business, and entrepreneurship. It aims to equip high-achieving individuals with the skills to translate scientific research into commercial ventures through integrated coursework, practical projects, industry placements, and international exposure.
Not enough reviews to generate pros and cons
The MPhil in Bioscience Enterprise (MBE) at the University of Cambridge is a multidisciplinary program combining biotechnology, business, and entrepreneurship. It aims to equip high-achieving individuals with the skills to translate scientific research into commercial ventures through integrated coursework, practical projects, industry placements, and international exposure.
Not Available in Not Available
400 Students
AI/ML, Systems, Theory, Human-Computer Interaction
Access to cutting-edge research labs and industry partnerships
107.0
Starting 2025-10-01
Apply before 2025-05-01
Oct-25, October2026-2026, 2026-01-01 00:00:00, 2026-04-01 00:00:00
Course overview: The MBE programme provides graduates with training in the latest advances in exploitable biotechnology, together with knowledge and understanding of business practice, and innovation in biotechnology companies and other commercial entities.
Applicants must hold a minimum of a UK II.i Honours Degree or equivalent in physical or life sciences, medicine, economics, or law. Postgraduate experience in industry or academia is advantageous but not mandatory. International applicants should verify their qualifications against local standards to ensure eligibility.
₹43,86,131/Year
Annual Fee
9 months
Total Duration
No Living costs available.
No University Scholarships Available
N/A
Amount
1250 USD
Deadline
Not specified
N/A
Amount
Various benefits
Deadline
Not specified
N/A
Amount
Various benefits
Deadline
Not specified
N/A
Amount
2000 USD
Deadline
15 Apr 2025
N/A
Amount
300 EUR
Deadline
Anytime
No Eligibility Requirements Available
No Application Steps Available
No news articles found